Regulation of biopharmaceuticals, tissue engineering and biogenerics: Key issues for the developer

Outi Oila

    Research output: Book/ReportBookGeneral public

    Original languageEnglish
    Place of PublicationEspoo
    Number of pages60
    Publication statusPublished - 2005
    MoE publication typeE2 Popularised monograph

    Keywords

    • Biopharmaceuticals, regulation, EMEA, FDA, tissue engineering, biogeneric, risk management

    Cite this